Mr. Kirk Look reports
ONCOLYTICS BIOTECH TO HOST CONFERENCE CALL TO DISCUSS FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS
Oncolytics Biotech Inc. will host a conference call and webcast on Friday, March 5, 2021, at 8:30 a.m. ET to discuss a corporate update and financial results for the fourth quarter and full year 2020.
Conference call and webcast
Date: Friday, March 5, 2021
Time: 8:30 a.m. ET
Dial-in number -- North American toll-free: 888-231-8191
Dial-in number -- international: 647-427-7450
Conference ID (if needed): 569-6653
Webcast: available on-line
A live webcast of the call will also be available on the investor relations page of Oncolytics's website and will be archived for three months. A dial-in replay will be available for one week and can be accessed by dialling 855-859-2056 (North America) or 416-849-0833 (international) and using reference code 569-6653.
About Oncolytics Biotech Inc.
Oncolytics is a biotechnology company developing pelareorep, an intravenously delivered immuno-oncolytic virus. The compound induces selective tumour lysis and promotes an inflamed tumour phenotype -- turning cold tumours hot -- through innate and adaptive immune responses to treat a variety of cancers.
We seek Safe Harbor.
© 2021 Canjex Publishing Ltd. All rights reserved.